嘉必优生物技术（武汉）股份有限公司2025年第二次临时股东大会决议公告
Filed with SSE ·
On 6ix: 6ix.com/news/2025-83
6ix hasn’t read this filing yet.
CABIO Biotech (Wuhan) Co. Ltd. on 6ix
Earlier from CABIO Biotech (Wuhan)
- Announcement on Litigation Progress and Final Judgment Victory
- Announcement on Canceling the Board of Supervisors, Changing Registered Address, Amending the "Articles of Association", and Formulating and Revising Some Governance Systems
- Announcement on Voluntary Disclosure of Expected Increase in Performance for the First Three Quarters of 2025
- Announcement on Self-Inspection Report on Trading Situation of Relevant Entities in Stock Market Concerning Termination of Issuing Shares and Paying Cash for Asset Acquisition, Raising Matching Funds, and Related Party Transaction
- Announcement on Initially Repurchasing the Company's Shares through Phase II Call Auction
Later from CABIO Biotech (Wuhan)
- CABIO Showcases Life-Stage Nutrition Innovation at Fi Europe 2025 Paris as the New Global Headquarter Opens
- Announcement on Convening the Q3 2025 Performance Briefing
- Announcement on Closing Some Investment Projects Financed by Raised Funds, Using Residual Raised Funds to Permanently Supplement Current Capital, and Cancellation of Related Special Account for Raised Funds
- Announcement on Progress in Repurchasing Shares through Call Auction in Phase II
- Announcement on Implementation Result of Phase II Shares Repurchase and Share Changes
Follow CABIO Biotech (Wuhan) into a list and get an email when it puts out news.
Follow CABIO Biotech (Wuhan)